Core Viewpoint - The Hong Kong stock market experienced a significant rise today, with major indices showing strong performance, particularly in the biotechnology and online retail sectors [1] Group 1: Market Performance - The Hang Seng Index increased by 1.35% and the Hang Seng Tech Index surged by 2.46% [1] - The total market turnover reached 226.855 billion HKD [1] Group 2: Sector Performance - The online retail sector showed strong gains, with Meituan (03690.HK) rising by 6.6%, Kuaishou (01024.HK) increasing by nearly 5%, and both Baidu (09888.HK) and Alibaba (09988.HK) up by nearly 2% [1] - The biotechnology sector also performed well, with WuXi AppTec (02126.HK) soaring by nearly 20% and WuXi Biologics (02269.HK) rising over 10% [1] Group 3: Specific Company Highlights - Hong Kong Exchanges and Clearing (00388.HK) was notably active, reaching an intraday high of 2.56% before closing up 2.4% at 400.4 HKD, marking the highest price since February 2022 [1]

Group 1 - Morgan Stanley's research report indicates that improvements in the Hong Kong Stock Exchange's new listing channels and the potential return of Chinese concept stocks (with a total market value of $237 billion for 26 unlisted Chinese concept stocks) will benefit the long-term development of the Greater China stock market, with an expected 6% increase in earnings per share for the Hong Kong Stock Exchange by 2026 if all return to the Hong Kong market [1] - The Hong Kong stock market is experiencing a surge in technology company listings, with several core technology firms preparing to list in Hong Kong, positioning the exchange as a global technology capital hub [1] - The Shenzhen Financial Management Bureau has revealed plans to promote Greater Bay Area companies to list in Hong Kong and encourage H-share companies to return to the Shenzhen Stock Exchange, further deepening the financial market connectivity between the two regions [1] Group 2 - CITIC Securities points out that Hong Kong's capital market has formed a complete and developed financial system, with significant weights in finance, real estate, technology, and consumer sectors [1] - Benefiting from the global reassessment of Chinese assets and national policy support, the Hong Kong stock market is becoming a strategic location for global capital allocation of Chinese technology assets [1] - With the optimization of Hong Kong's listing rules (18A, 18C, and "Special Line for Technology Enterprises"), high-quality Chinese technology companies are accelerating their listings in Hong Kong, pushing the market into a new era of Chinese technology [1] Group 3 - Continuous inflow of southbound funds has led to the highest allocation ratio of active equity funds in Hong Kong stocks in nearly five years by the first quarter of 2025, with the technology sector increasingly becoming an important entry point for investing in China's technological rise [1] - The improvement in liquidity in the Hong Kong market, combined with the trend of Chinese concept stocks returning amid US-China tensions, has significantly increased the weight of the technology industry, with leading companies in core fields such as semiconductors, new energy, and cloud computing gathering in Hong Kong, highlighting its strategic position in the technology sector [1]

Core Viewpoint - The Hong Kong stock market is experiencing volatility, with Hong Kong Exchanges and Clearing Limited (HKEX) trading at 390.6 HKD, down 1.91%. The stock is currently in a sideways movement above the midline on the daily chart, while the weekly chart shows a positive trend with seven consecutive weeks of gains, nearing the upper Bollinger Band at 400.65 HKD [1]. Technical Analysis - The current price of HKEX is at a critical divergence point, with multiple moving averages indicating a "strong buy" signal. However, the RSI has reached 77, indicating an overbought condition, and there is significant pressure at the upper Bollinger Band [1]. - Key support has shifted from resistance at 380 HKD to a strong support level, while the next target for bulls is the range of 406-415 HKD [1]. - Market participants are particularly focused on the 400 HKD level, with some considering short positions at this price point [2]. Derivative Products - In the options market, various call options are available, such as the Morgan Stanley call option (13652) with a leverage of 7.9 times and a strike price of 450.2 HKD, suitable for investors optimistic about breaking this price level. Another option, the Barclays call option (27807), offers 8.7 times leverage with a strike price of 450 HKD, noted for its cost-effectiveness [4]. - For bearish investors, Citigroup's put option (16606) provides 8.4 times leverage with a strike price of 333.9 HKD, while Morgan Stanley's put option (16907) offers 8.2 times leverage with a strike price of 333.68 HKD [4]. Market Sentiment - The market sentiment remains bullish, with investors closely monitoring the performance of HKEX as it approaches the 400 HKD resistance level. The trading strategies often involve gradually exiting positions as the stock price rises or deploying derivatives when reaching significant price points [2]. - Notably, when HKEX shares rose by 1.76%, related bullish derivative products performed exceptionally well, with notable increases of 36% for the Societe Generale bull certificate (54739) and 31% for the UBS bull certificate (54530) [2].

陈翊庭提到，目前港交所对接的储备项目中主要包含三类：已经在亚洲市场上市，现寻求融资的公司； 美国市场回流的中概股；以及新兴的独角兽和创新企业。 21世纪经济报道记者 张伟泽 实习生 莫林卫 香港报道 5月28日，港交所行政总裁陈翊庭在大中华私募投资高峰会上表示，目前有超150家企业正排队等候在港 上市，其中不少是集资规模超10亿美元的超大型企业。除此之外，香港在上市企业的后续融资中也表现 出色。自年初至今，融资额已接近200亿美元。 她提到，在过去几周中，她与很多在美国上市的中国企业有过沟通，他们都表示投资者要求这些公司制 定"PlanB"，以应对被摘牌的风险。这是中概股回流香港的主要推动因素。同时，进入港股通也吸引中 概股回流香港。港股市场特有的"港股通"机制可为企业带来增量资金，这对公司估值提升与二级市场流 动性改善具有显著助益。 对于第三类企业，陈翊庭指出，港交所从2018年开始推出了"18章系列"的上市规则，允许满足条件的未 盈利企业来港上市。此前港交所倾向于成熟的公司上市，但如今观念已显著改变，港交所认为需要精准 定制适合特定类型公司的上市框架。未来"18章系列"上市规则仍有可能扩展。 陈翊庭指出， ...

Investment Rating - The report assigns a "Neutral" rating to Hong Kong Exchanges and Clearing Limited (00388) with a target price of HKD 340 for the next 12 months [1] Core Insights - The report highlights that improvements in the new stock listing channels for Hong Kong Exchanges are a significant long-term benefit for the Greater China stock market, as the Stock Connect programs have fundamentally changed the investment landscape for both Hong Kong and mainland Chinese investors since their launch in 2014 [1] - It mentions that there are 26 Chinese concept stocks, which are constituents of the MSCI China and FTSE China indices, that have not yet been listed in Hong Kong, with a total market capitalization of USD 237 billion and an average daily trading volume of USD 2 billion over the past three months, representing approximately 5% and 6% of Hong Kong Exchanges' current market capitalization and daily trading volume, respectively [1] - According to sensitivity analysis, if all these stocks were to list in Hong Kong, it is anticipated that the earnings per share for Hong Kong Exchanges would increase by 6% by 2026 [1]

Group 1 - BlackRock's stake in AIA decreased from 6.03% to 5.90% as of May 22 [1]

Core Viewpoint - Hong Kong Stock Exchange (HKEX) has seen a significant increase in IPO activities in 2023, with total fundraising exceeding 76 billion HKD, a more than sevenfold increase compared to the same period last year, positioning it as the top global fundraising venue for IPOs in 2025 [2][3]. Group 1: IPO Market Performance - As of May 21, 2023, HKEX has welcomed 23 new listings, including notable companies like Mixue Ice City and CATL, which have set new records for IPO subscriptions and fundraising [2]. - The fundraising amount in Hong Kong has approached 90% of the total for the previous year, reflecting a strong recovery in the IPO market [2]. - HKEX has received nearly 100 IPO applications and is processing around 150 applications, indicating a robust pipeline of potential listings [3]. Group 2: Policy Changes and Market Reforms - The launch of the "Tech Company Fast Track" aims to streamline the listing process for technology and biotech companies, allowing confidential submissions and creating a "green channel" for these firms [4][5]. - HKEX has been progressively adjusting its policies to attract more high-growth tech companies, including the introduction of new listing frameworks and lowering entry barriers for specialized tech firms [4][5]. - Recent reforms to the IPO pricing mechanism are considered the most comprehensive in three decades, aimed at enhancing market competitiveness and improving the efficiency of new stock pricing [5]. Group 3: Trends in Listings - There is a notable trend of companies opting for "A+H" listings, with over 40 companies already applying or announcing plans to list in Hong Kong after being listed in mainland China [6]. - The return of Chinese concept stocks to Hong Kong is anticipated, with many companies considering dual listings or secondary listings in response to favorable market conditions [6][7]. - International companies, including those from Singapore and Thailand, are also increasingly choosing HKEX for their listings, further diversifying the market [7]. Group 4: Financial Performance and Future Outlook - HKEX has reported record financial results, with total revenue and other income reaching 22.4 billion HKD in 2024, a 9% increase from 2023 [8]. - The first quarter of 2025 saw HKEX achieving historical highs in both revenue and profit, with revenue of nearly 6.9 billion HKD, a 32% year-on-year increase [8]. - Strategic initiatives are underway to enhance liquidity and market vitality, including partnerships to expand the range of fixed income and currency products [9].

5月26日，香港交易及结算所有限公司（简称"港交所"）股价盘中一度创2022年2月以来新高。今年以 来，香港新股集资额超过760亿港元，较去年同期增加超过七倍，并已达到去年全年新股集资总额的九 成左右。 多重利好叠加下，2025年以来，A股上市公司赴港上市明显提速。今年年初以来，完成香港IPO的企业 数量已经达到32家，募集资金总额是27亿美元，比去年同期上涨近130%。同时，香港资本市场年初至 今的配售H股、红筹、可转债的募集金额整体超过了200亿美元。 从今年港交所已经发行的新股特点来看，生物医药、新能源、科技、消费等行业领衔，此外在A+H发 行审批加速的背景下，A股已上市公司提出IPO申请的数量逐渐增多。截至5月23日，累计递交尚未获批 复的公司超过140家，仅5月就有三一重工、三只松鼠、广和通等企业递交申请。 5月20日，新能源龙头企业宁德时代正式登陆港交所主板，并以约355亿港元的IPO募资总额，荣登今年 全球规模最大的IPO宝座。宁德时代新股的上市令香港今年的新股融资规模暂居全球首位。 市场人士指出，选择在香港上市是增加企业知名度和品牌影响力的重要手段，香港作为全球重要的金融 中心，来自世界各地的 ...

Group 1 - As of May 26, a total of 88 stocks reached their 52-week highs, with Tianbao Energy (01671), China Nuclear International (02302), and Honghui Group (00183) leading the high rate at 141.60%, 93.92%, and 21.34% respectively [1] - Tianbao Energy closed at 0.700 and reached a peak of 1.510, marking a significant increase of 141.60% [1] - China Nuclear International closed at 4.090 with a highest price of 5.100, reflecting a rise of 93.92% [1] Group 2 - Other notable stocks that reached their 52-week highs include Century International (00959) with an increase of 18.64%, and Junjie Group Holdings (08188) with a rise of 17.95% [1] - The list also includes Haotian Financial Group (01260) with a 13.70% increase and Dechang Electric Holdings (00179) with a 10.96% rise [1] - The overall trend indicates a strong performance in the market, with multiple stocks achieving significant gains [1] Group 3 - The report also highlights stocks that reached their 52-week lows, with Sipai Health (00314) showing the largest decline at -11.65% [3] - Other stocks experiencing declines include Feitian Yundong (06610) at -9.05% and Hengrui Medicine (01276) at -4.81% [3] - The presence of stocks reaching both highs and lows suggests a volatile market environment [3]

Group 1: Market Overview - The report indicates that the U.S. stock market experienced a decline last Friday, with the Dow Jones Industrial Average down by 0.61% and the S&P 500 down by 0.67% [2] - The Hang Seng Index closed at 23,601, up 0.2%, while the Shanghai Composite Index fell by 0.94% to 3,348.37 [3] - The overall market turnover for the day was 203.67 billion [3] Group 2: Macroeconomic and Industry Dynamics - The report highlights that China's self-regulatory mechanism has lowered the upper limit for bank deposit rates, with some banks reducing rates by 30 to 40 basis points, indicating regulatory efforts to improve banks' net interest margins [6] - The Hong Kong Insurance Authority is actively communicating with insurance companies interested in relocating their registrations to Hong Kong, aiming to facilitate the migration process under a new framework [7] Group 3: Company-Specific News - UBS has raised its year-end target for the S&P 500 index from 5,800 to 6,000, citing better-than-expected first-quarter earnings and improved GDP growth expectations as reasons for the adjustment [8] - The Hong Kong Stock Exchange plans to increase the position limits for Hang Seng Index derivatives starting July 2, pending regulatory approval, to enhance the development of the derivatives market [10] - Country Garden has reported that over 70% of its public noteholders have joined a restructuring support agreement, extending the deadline for early bird participation [11]